1. Home
  2. ZURA vs CVGW Comparison

ZURA vs CVGW Comparison

Compare ZURA & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$3.71

Market Cap

455.4M

Sector

Health Care

ML Signal

HOLD

Logo Calavo Growers Inc.

CVGW

Calavo Growers Inc.

HOLD

Current Price

$25.98

Market Cap

479.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZURA
CVGW
Founded
2022
1924
Country
United States
United States
Employees
40
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Specialty Foods
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
455.4M
479.9M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
ZURA
CVGW
Price
$3.71
$25.98
Analyst Decision
Buy
Buy
Analyst Count
6
2
Target Price
$13.00
$33.50
AVG Volume (30 Days)
856.3K
285.1K
Earning Date
05-14-2026
06-08-2026
Dividend Yield
N/A
2.85%
EPS Growth
N/A
1950.00
EPS
N/A
0.04
Revenue
N/A
$648,434,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$652.25
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$18.40
52 Week High
$7.25
$28.98

Technical Indicators

Market Signals
Indicator
ZURA
CVGW
Relative Strength Index (RSI) 37.96 36.34
Support Level $3.25 $25.41
Resistance Level $4.12 $26.86
Average True Range (ATR) 0.25 0.44
MACD 0.00 -0.16
Stochastic Oscillator 39.50 6.73

Price Performance

Historical Comparison
ZURA
CVGW

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

About CVGW Calavo Growers Inc.

Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.

Share on Social Networks: